Canada / Product Areas / Vascular Access

Central Access Portfolio

Arrowg+ard Blue Plus™ CVC

  • Broad-spectrum antimicrobial CVC that protects against fungi, gram-positive bacteria, and gram-negative bacteria
  • Antimicrobial protection provides complete coverage of the extension lines, hubs, and both interior and exterior surfaces of the catheter1
  • In vitro performance has shown proven effectiveness against common antibiotic-resistant “superbugs”2
  • Available in Arrow™ ErgoPack™ Complete System, designed to optimize efficiency and improve outcomes3-6
Learn More
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_01

Arrow™ PICCs

  • Arrowg+ard Blue Advance™ PICCs and traditional PICCs available
  • Teleflex is committed to supporting interventional radiologists and vascular access specialists in their efforts to reduce vascular-related complications
  • We offer the world's only antimicrobial and antithrombogenic PICC*
  • Using Arrowg+ard Blue Advance™ PICCs will help guard against CLABSI-causing pathogens in areas that are clinically out of reach7
    • This protection lasts while the line is in the patient for at least 30 days8,9
Visit myteleflex.com to see the Arrowg+ard Blue Advance™ PICCs and traditional PICCs
Learn More

*As of April 2024.

Product Image

Arrowg+ard Blue™ Multi-Lumen Access Catheter

  • Combines the access of a sheath introducer with the high-flow lumens of a central line
  • 9 French distal lumen accommodates large fluid volumes when needed, while the 12-gauge proximal lumen provides a separate access for incompatible fluid administration
  • Uses proprietary chlorhexidine-based antimicrobial protection designed to protect your patients from the known pathogens of catheter-related bloodstream infections (CRBSIs)
Learn More
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_06

Arrowg+ard Blue™ Percutaneous Sheath Introducer

  • Designed to provide optimal access for hemodynamic monitoring
  • Hemostasis valve also allows easy access for additional devices such as thermodilution catheter or PSI companion catheter
  • Inner lumen accommodates large fluid administration for fast resuscitation
  • Uses proprietary chlorhexidine-based antimicrobial protection designed to protect your patients from the known pathogens of catheter-related bloodstream infections (CRBSIs)
Learn More
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_07

Arrowg+ard Blue™ Acute Hemodialysis Catheter

  • Protection for those who need it most
    • Supported by 30+ clinical studies, our proprietary chlorhexidine-based antimicrobial Arrowg+ard Blue™ Technology reduces central line-associated bloodstream infection (CLABSI), the second leading cause of death in hemodialysis patients10-12
    • Chlorhexidine-based antimicrobial protection combats infection by inhibiting microorganisms from migrating along the exterior surface of the catheter12
  • Achieve high flows at low arterial pressures13
    • Deliver high flow rates up to 400 mL/min at low arterial pressures with our 14 French large-bore, double-lumen acute hemodialysis catheters
Learn More
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_08

The first and only long-term antimicrobial14 and antithrombogenic15 CVC.

  • The Arrowg+ard Blue Advance™ Jugular Axillo-Subclavian Central Catheter (JACC) is ideal for both the short-term and long-term dwell needs of your complicated patients
  • Multiple length and lumen configurations to accommodate jugular, subclavian, or axillary insertion
Learn More
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_09

Peripheral Access Portfolio

  • The Arrow™ Pressure Injectable Midline family features easily identifiable hubs, pinch clamps, and labeling to help alleviate midline identification confusion. Choose between traditional or our Arrowg+ard Blue Advance™ Midlines, the only midline featuring antimicrobial and antithrombogenic protection8,16
    • Unique hub design and color allow for easy catheter identification to reduce catheter confusion and promote patient safety
    • Additional midline catheter identification sticker and over bed sign, for extra awareness
    • Infuse with confidence
  • Visit myteleflex.com to see the Arrowg+ard Blue Advance™ Midlines and traditional Midlines
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_02

Offering dual-infusion management through two distinct non-communicating lumens, the Arrow™ Twin Cath™ Two-Lumen Peripheral Catheter is ideal for use in the emergency room, operating room, or ICU and by qualified EMS personnel.

  • Administer peripherally compatible therapies simultaneously through a single peripheral site
  • Reduces the risk of chemical precipitates at normal flow rates through the cephalic, basilica, median, cubital, and axillary veins with a flow-designed separation of ports17-19
  • Enables discrete blood sampling
Learn More
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_10

Teleflex offers a range of peripheral access and central access accessories.

  • Arrow-Johans™ ECG Adapter Kit
    • Arrow-Johans™ Adapter Kit is indicated for placing central venous catheters with ECG technology to include CVCs and dialysis catheters
  • Access/Insertion Sets & Trays
    • The Arrow™ MST Insertion Kit from Teleflex features the patented, peel-away Arrow™ GlideThru™ Sheath and all components you need for easy insertion of compatible vascular access devices employing the Modified Seldinger Technique. This includes PICCs, Midlines, and the Arrow™ JACC. The GlideThru™ Sheath is also color-coded by French size for easy identification.
  • Arrow™ GlideThru™ Peel-Away Sheaths
    • The Arrow™ GlideThru™ Peel-Away Sheath/Dilator Introducer is used for percutaneous introduction of diagnostic or therapeutic devices into the vasculature
  • Introducer Needles
    • Teleflex offers a range of individually sold, echogenic, introducer needles to support the access needs of our customers and the Arrow™ Vascular Access product line
Learn More
Image_Arrow-Pressure-Injectable-PICC-insertion-kit_2 VA_VPS_Rhythm-Johans_Adaptor1 GlideThru

Arterial Portfolio

  • Our easy-to-use Arrow™ Arterial Catheters are designed with your team’s efficiency and safety in mind, with several designs to best meet your insertion needs
  • Featuring a catheter-over-needle design, the Arrow™ Integrated Arterial Catheter enables quick and easy insertions. Available with a Sharps Safety capability
PROP-P00102583---TFX-Canadian-Vascular-Access-Landing-Page_BODY-IMAGES_2x_03
Learn More

Its flexible, streamlined design helps contribute to quicker placement, easier handling, and shorter procedure times.

RA-04220-W_QuickFlash_radial_artery_cat_set
Learn More

Designed with flexible suture wings and a separate guidewire to help deliver a precise, atraumatic insertion. To promote safety for your patients, it utilizes an integrated extension line that is designed to reduce the risk of contamination and improve efficiency.

Learn More
SAC-00820_Arrow-Arterial-Catheterisation-Set-new

Catheter Tip Positioning System

  • Our next-generation Arrow™ VPS Rhythm™ DLX Device features an optional ultrasound20
  • The Arrow™ VPS Rhythm™ DLX Device is available in 5 configurations20
    1. Ultrasound with TipTracker™ Technology and ECG
    2. TipTracker™ Technology and ECG
    3. Ultrasound with ECG
    4. ECG only
    5. Ultrasound only
  • Designed to give Vascular Access Specialists more efficient and predictable procedures while continuing to maximize patient safety with Arrowg+ard Blue Advance™ Antimicrobial and Antithrombogenic Technology20-22
Learn More

Want to learn more or schedule a product demo/trial?


By completing this form, you consent to your preferred language being English. If you prefer French, please complete the French form.


References:

  1. 510(k) Premarket Notification: ARROWg+ard and Blue Plus™ Antimicrobial Central Venous Catheter. March 8, 2000. Accessed April 17, 2024. https://www.accessdata.fda.gov/cdrh_docs/pdf/K993691.pdf
  2. Gupta N, Weber H, Moss S, Gaire-Patel K. Are antibiotic-resistant ‘superbugs’ a real challenge to antimicrobial central venous catheter performance? Poster presented at: Annual Meeting of the Association for Vascular Access 2014; September 7-10, 2014; National Harbor, MD.
  3. O'Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-e193. doi:10.1093/cid/cir257
  4. Buetti N, Marschall J, Drees M, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2022;43(5):553-569. doi:10.1017/ice.2022.87
  5. Nickel B, Gorski LA, Kleidon TM, et al. Infusion therapy standards of practice. J Infus Nurs. 2024;47(suppl1):S1-S285. doi:10.1097/NAN.0000000000000532
  6. 1910.1030 - Bloodborne pathogens. US Department of Labor; Occupational Safety and Health Administration. Accessed April 17, 2024. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030
  7. ADHX-001612: Design History File Index for VPS Rhythm™ DLX System.
  8. As compared to uncoated PICCs, intravascular ovine model inoculated with Staph aureus: AVAR-000427. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.
  9. In vitro data on file 2010: AVER-004371, AVER-004483 and AVAR-000427. No correlation between in vitro/in vivo testing methods and clinical outcomes has currently been ascertained.
  10. Weiss S, Qureshi M. Evaluating a novel hemodialysis central venous catheter cap in reducing bloodstream infections: a quality improvement initiative. Int J Nephrol Renovasc Dis. 2021;14:125-131. doi:10.2147/IJNRD.S304605
  11. Arrowg+ard Blue® Protection Clinical References MC-004390.
  12. AGB AHD IFU- S-22142-105C.
  13. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA. 1999;282(6):554-560. doi:10.1001/jama.282.6.554
  14. In vitro data on file 2010. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.
  15. As compared to uncoated PICCs, intravascular ovine model inoculated with Staph aureus. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.
  16. In vitro data on file 2010: AVER-004371 and AVER-004483. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.
  17. Chapolini RJ. Incompatible drug infusion through the Arrow two-lumen catheter—an in vitro analysis. White Marsh Labs, Baltimore, MD. Unpublished, April 1987.
  18. Jaimovich DG, Rose WW. In vivo evaluation of simultaneous administration of incompatible drugs via a double-lumen peripheral catheter. Crit Care Med. 1990;18(10):1164-1166. doi:10.1097/00003246-199010000-00022
  19. Prince RA, Lucas DS, Fox JL. Effect of a dual-lumen peripheral catheter on the delivery of known incompatible medications. Ann Pharmacother. 1998;32(9):875-877. doi:10.1345/aph.18042
  20. DLX-200-OPM-US: VPS Rhythm™ DLX Operator's Manual.
  21. D041679: IMH Benchtop Stylet Advancement in a Simulated Use Anatomical Model of NaviCurve™. Product Stylet/PICC Assemblies.
  22. Antimicrobial – In vitro data on file 2010; AVER-004371, AVER-004483, AVAR-000427.

Rx only

Refer to the Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions.

Contraindications:
Arrowg+ard Blue™ and Arrowg+ard Blue Plus™ Catheters are contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.

Clinical assessment of the patient must be completed to ensure no contraindications exist.

The Arrowg+ard Blue Advance™ Catheters are contraindicated in the following areas:

-Patients with known hypersensitivity to chlorhexidine
-In presence of device-related infections
-In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway.

No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue, Arrowg+ard Blue Advance, Arrowg+ard Blue Plus, Arrow-Johans, ErgoPack, GlideThru, QuickFlash, TipTracker, TwinCath, and VPS Rhythm are trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MC-009786